Concepedia

M.J. Rodrigues

MR

Statistics

Publications

1

Citations

15

H-Index

1

Active since

2022

Affiliations

Institut Curie(Current)

M.J. Rodrigues is an author at Institut Curie specializing in cancer pharmacology, medicine, and ovarian cancer recurrence.

Publications per year

2022–2022

1

Publications

1

LBA30 Phase III ATALANTE/ov29 trial: Atezolizumab (Atz) versus placebo with platinum-based chemotherapy (Cx) plus bevacizumab (bev) in patients (pts) with platinum-sensitive relapse (PSR) of epithelial ovarian cancer (OC)

J.E. Kurtz, E. Pujade-Lauraine, A. Oaknin et al. · Annals of Oncology · 2022 · 15 citations

Medicine, Oncology, Pharmacology +17

1–1 of 1